Mr. Hermes Chan reports

MEDMIRA ANNOUNCES THE HIRE OF VICE PRESIDENT OF BUSINESS DEVELOPMENT

Medmira Inc. has expanded its commercialization team by welcoming Rene Bell to the position of vice-president of business development.

Ms. Bell brings over 20 years of business development and sales experience in the U.S. and international markets. Her extensive knowledge of the U.S. health care market, coupled with her deep understanding of technical intricacies, positions her as a key asset in Medmira's growth strategy. Her past contributions at companies such as Akers Bioscience have been pivotal in forging significant partnerships and driving sales. In her new role, Ms. Bell will focus on increasing direct sales in the short term and establishing additional partnerships with new distributors. Additionally, she will spearhead the formation of a dedicated United States-based team to support existing partners like VWR, Cardinal Health, Medline and additional new partners, thereby maximizing sales opportunities.

"We truly believe that our technology and products are one of the best in the market. While our technical capabilities have been proven to be of the highest quality, we require to expand our talents to market Medmira's products in a fast and sustainable way. Rene has an abundance of such skills, and her past work is a testament to her expertise," said Hermes Chan, chief executive officer of Medmira. "We know that she will leverage her expertise to support Medmira's growth strategy and significantly contribute to our sales, and with it, substantially increase our revenues in both short term and long term."

Ms. Bell's appointment marks a significant milestone in Medmira's 2024 strategy, which aims to aggressively expand its presence in the U.S. market. With a focus on its current G4 HIV and Miriad product lines, as well as coming innovations like the G4 CLIA waived product line, Medmira is poised for continued success under Ms. Bell's guidance.

About Medmira Inc.

Medmira is a leading developer and manufacturer of rapid vertical flow diagnostics. The company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as HIV, syphilis, hepatitis and SARS-CoV-2, in just three easy steps. The company's tests are sold globally under the Reveal, RevealCOVID-19, Multiplo and Miriad brands. Based on its patented rapid vertical flow technology, Medmira's rapid HIV test is the only one in the world to achieve regulatory approvals in Canada, the United States, China and the European Union. Medmira's corporate offices and manufacturing facilities are located in Halifax, N.S., Canada.

We seek Safe Harbor.